Recognition highlights commercial potential of Telo’s telomere-based MRD technology in the growing precision oncology market Toronto, Ontario–(Newsfile Corp. – October 9, 2025) – Telo Genomics Corp.

Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Proteomic techniques now measure thousands of ...

AI-enabled genomic and multi-omics testing now available locally in Lagos through a new sequencing laboratory Launch portfolio includes hereditary cancer and conditions panels, somatic oncology panels ...

Overview of the process of obtaining genomic diversity of influenza virus in a population replicated from a single particle. (a) MDCK cells were infected with influenza vi ...

This cover highlights the article Programmed cell revival from imminent cell death enhances tissue repair and regeneration by Kollori Dhar, Kautilya Kumar Jena, Santosh Chauhan and colleagues. The ...